ym 529 has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawaguchi, T; Kawai, N; Nakazawa, T; Taniguchi, S; Tojo, T; Tsujimura, T; Yasukawa, M | 1 |
| Aoe, M; Date, H; Hara, F; Koshimune, R; Ouchida, M; Sano, Y; Shimizu, N; Tokumo, M; Toyooka, S | 1 |
2 other study(ies) available for ym 529 and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Minodronic Acid in Combination with γδT Cells Induces Apoptosis of Non-small Cell Lung Carcinoma Cell Lines.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transplantation; Diphosphonates; Humans; Imidazoles; Lung Neoplasms; Receptors, Antigen, T-Cell, gamma-delta | 2016 |
Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Dose-Response Relationship, Drug; Humans; Imidazoles; Lung Neoplasms | 2007 |